Caris Life Sciences, Inc.
CAI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$282 | -$341 | -$321 | $28 |
| Dep. & Amort. | $49 | $49 | $48 | $111 |
| Deferred Tax | $0 | $0 | $0 | $1 |
| Stock-Based Comp. | $19 | $15 | $23 | $2 |
| Change in WC | -$29 | -$7 | -$22 | -$317 |
| Other Non-Cash | -$2 | $8 | -$14 | $453 |
| Operating Cash Flow | -$245 | -$276 | -$286 | $277 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | -$22 | -$42 | -$219 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$63 | -$378 | $0 |
| Inv. Sales/Matur. | $61 | $300 | $138 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $185 |
| Investing Cash Flow | $53 | $215 | -$283 | -$34 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $200 | $11 | -$1 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$8 |
| Dividends Paid | $0 | $0 | $0 | -$18 |
| Other Fin. Act. | $0 | -$0 | $11 | -$232 |
| Financing Cash Flow | $200 | $10 | $10 | -$250 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8 | -$51 | -$558 | -$7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60 | $111 | $669 | $73 |
| End Cash | $68 | $60 | $111 | $67 |
| Free Cash Flow | -$254 | -$298 | -$328 | $58 |